🔎 Trials Near Me

Home › Neuroendocrine Tumors › Iowa

Pag-aaral pangklinika para sa Neuroendocrine Tumors sa Iowa

7 pag-aaral para sa Neuroendocrine Tumors ang naghahanap ng mga kalahok sa mga site sa Iowa.

Mga Lungsod sa Iowa

Opisyal na teksto ng pag-aaral (English)

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

  • University of Iowa Health Care, Iowa City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07087054

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

  • Research Facility, Iowa City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07165132

Project: Every Child for Younger Patients With Cancer

  • Blank Children's Hospital, Des Moines
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

Integrated Cancer Repository for Cancer Research

  • Methodist Jennie Edmundson Hospital, Council Bluffs
  • Covenant Medical Center, Inc, Waterloo
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

  • University of Iowa, Iowa City
Nagre-recruitPhase 1/2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update May 14, 2026 · NCT05636618

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Iowa City
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

  • Holden Comprehensive Cancer Center at the University of Iowa, Iowa City
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2025 · NCT06395402

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.